Literature DB >> 15528917

Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.

Hideto Nakajima1, Kazuhiro Fukuda, Yoshimitsu Doi, Masakazu Sugino, Fumiharu Kimura, Toshiaki Hanafusa, Toshiyuki Ikemoto, Akira Shimizu.   

Abstract

Th1 cells play an important role in the pathogenesis of multiple sclerosis (MS), a disease likely linked to an autoimmune process. We measured the levels of chemokines in serum or cerebrospinal fluid (CSF) samples by ELISA, and also studied the expression of Th1-related CXCR3/CCR5 chemokine receptors and Th2-related CCR4/CCR3 chemokine receptors on blood cells from MS patients using three-color flow cytometry. The Bonferroni correction was used for the statistical analysis. The levels of CXCL10, CCL3, and CCL5 in the CSF samples for the MS groups were significantly higher than those for the control group. However, the levels of CCL2 in both the CSF and serum samples for the remission group were significantly higher than those for the active group. The percentage of CXCR3-expressing CD4+ T cells in patients with MS was significantly elevated compared with the healthy controls. Moreover, MS patients in an active phase showed a more increased CD4+CXCR3+/CD4+CCR4+ ratio than patients in a remission phase. The increased percentage of CD4+CXCR3+ cells in the blood was associated with relapses in MS. This study suggested that the CD4+CXCR3+/CD4+CCR4+ ratio could be a sensitive maker of immune dysfunction in MS. 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528917     DOI: 10.1159/000081856

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  12 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.

Authors:  Soudeh Ghafouri-Fard; Kasra Honarmand; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2021-01-06       Impact factor: 3.584

3.  Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis.

Authors:  Hideto Nakajima; Masakazu Sugino; Fumiharu Kimura; Toshiaki Hanafusa; Toshiyuki Ikemoto; Akira Shimizu
Journal:  Biomark Insights       Date:  2007-12-18

4.  Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli; E D Tate; N R McGee; A L Travelstead; S J Verhulst; R M Ransohoff
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

Review 5.  Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination.

Authors:  Trina A Johnson; Frank R Jirik; Sylvie Fournier
Journal:  Semin Immunopathol       Date:  2010-03-18       Impact factor: 11.759

6.  Involvement of beta-chemokines in the development of inflammatory demyelination.

Authors:  Ileana Banisor; Thomas P Leist; Bernadette Kalman
Journal:  J Neuroinflammation       Date:  2005-02-24       Impact factor: 8.322

Review 7.  Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Christine Riedhammer; Robert Weissert
Journal:  Front Immunol       Date:  2015-06-17       Impact factor: 7.561

Review 8.  Chemokines and chemokine receptors in multiple sclerosis.

Authors:  Wenjing Cheng; Guangjie Chen
Journal:  Mediators Inflamm       Date:  2014-01-02       Impact factor: 4.711

9.  Interferon-β1b increases Th2 response in neuromyelitis optica.

Authors:  Hideto Nakajima; Takafumi Hosokawa; Yoshimitu Doi; Toshiyuki Ikemoto; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  Int J Mol Sci       Date:  2012-09-25       Impact factor: 5.923

10.  Differential regulation of CD4+ T cell adhesion to cerebral microvascular endothelium by the β-chemokines CCL2 and CCL3.

Authors:  Kenneth Ky Liu; Katerina Dorovini-Zis
Journal:  Int J Mol Sci       Date:  2012-11-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.